Ángela Izquierdo de la Puente, Pablo del Sol Calderón, María García Moreno
{"title":"Guilles de la Tourette y epilepsia","authors":"Ángela Izquierdo de la Puente, Pablo del Sol Calderón, María García Moreno","doi":"10.1016/j.psiq.2024.100525","DOIUrl":"10.1016/j.psiq.2024.100525","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>We present the case of a male patient, who has been under follow-up since he was 12 years old due to obsessive symptomatology and phonological tics. After years of specific treatment for such symptomatology, at the age of 19 he debuts with complex generalized seizures, being diagnosed with epilepsy complex generalized seizures, being diagnosed with epilepsy. As a result of this case, a brief review is made on the relationship between both entities.</div></div><div><h3>Case presentation</h3><div>The patient began his follow-up in Mental Health at the age of 12, first with the infantile-juvenile team, being diagnosed with OCD. In view of this obsessive-compulsive disorder, his child and adolescent psychiatrist, in addition to prescribing treatment with sertraline 100 mg DMD, performed cognitive-behavioral therapy. After five years of treatment, the patient improved to such an extent that he was able to withdraw the pharmacological treatment and be discharged from follow-up care and he could be discharged from his follow-up in Mental Health.</div><div>After a year of stability, he was diagnosed with Gilles de la Tourette syndrome. For this reason, it was decided to start treatment again with sertraline 100 mg DMD and cognitive therapy. With the pharmacological treatment and psychotherapeutic follow-up, the symptomatology improves moderately, although without disappearing completely.</div><div>After six months of treatment with SSRIs and cognitive behavioral therapy, the patient debuted with a tonic-clonic seizure, which required hospital admission for study and diagnosis. He was diagnosed with epilepsy, receiving treatment with topiramate at 200 mg DMD. Since the beginning of anticonvulsant treatment, the symptomatology of tics has subsided until its disappearance.</div></div><div><h3>Discussion</h3><div>Although they are different entities, and it is necessary to perform an adequate differential diagnosis, it seems that both differential diagnosis is necessary, it seems that as much the crisis as the tics share similarities in their physiopathology. In addition to the classic treatments, antiepileptics can be used.</div></div>","PeriodicalId":39337,"journal":{"name":"Psiquiatria Biologica","volume":"32 1","pages":"Article 100525"},"PeriodicalIF":0.0,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142723890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Riesgo autolítico en la población adolescente","authors":"Ana Jiménez Bidón","doi":"10.1016/j.psiq.2024.100522","DOIUrl":"10.1016/j.psiq.2024.100522","url":null,"abstract":"<div><div>Suicidal behavior in adolescents has increased in recent years and consequently the psychiatric hospitalization due to the suicidal risk.</div><div>In this article, a study is carried out on adolescents who are psychiatric inpatients in the Hospital 12 de Octubre in Madrid. The reasons for admission to a psychiatric hospital are analyzed and they show that the most common reason is risk of self-injury, whether suicidal ideation or frustrated suicide attempt. The methods used in suicide attempts are also studied. The results obtained are discussed and the importance of establishing adequate measures for the prevention and intervention of suicidal behavior is emphasized.</div></div>","PeriodicalId":39337,"journal":{"name":"Psiquiatria Biologica","volume":"32 1","pages":"Article 100522"},"PeriodicalIF":0.0,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142743697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
María Parrondo Pérez-Olivares , Miguel Jiménez Blázquez
{"title":"Psicopatía y tratamiento de la responsabilidad criminal","authors":"María Parrondo Pérez-Olivares , Miguel Jiménez Blázquez","doi":"10.1016/j.psiq.2024.100518","DOIUrl":"10.1016/j.psiq.2024.100518","url":null,"abstract":"<div><div>Spanish jurisprudence does not declare psychopathy as an exculpatory circumstance from criminal liability, understanding that, although it may be considered as a psychological alteration, the assessment of the intellectual and volitional capacities does not prevent the person from being responsible for their actions.</div></div>","PeriodicalId":39337,"journal":{"name":"Psiquiatria Biologica","volume":"32 1","pages":"Article 100518"},"PeriodicalIF":0.0,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142700600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Miguel Jiménez Blázquez , María Parrondo Pérez-Olivares
{"title":"Evaluación de la capacidad de hecho en interconsulta psiquiátrica","authors":"Miguel Jiménez Blázquez , María Parrondo Pérez-Olivares","doi":"10.1016/j.psiq.2024.100519","DOIUrl":"10.1016/j.psiq.2024.100519","url":null,"abstract":"<div><div>The evaluation of a possible inability to make decisions must be careful to respect the principle of patient autonomy and to preserve the ethical principle of non-maleficence. The presumption that the patient retains his de facto capacity must always prevail. The Aid to Capacity Evaluation is the most appropriate tool for assessment in Liaison Psychiatry.</div></div>","PeriodicalId":39337,"journal":{"name":"Psiquiatria Biologica","volume":"32 1","pages":"Article 100519"},"PeriodicalIF":0.0,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142697928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Síndrome de encefalopatía posterior reversible tras la terapia electroconvulsiva","authors":"Andrea Jiménez-Mayoral , Emilio Ruiz-Fernández , Aurora Torrent-Seto , Iolanda Batalla-Llordes","doi":"10.1016/j.psiq.2024.100515","DOIUrl":"10.1016/j.psiq.2024.100515","url":null,"abstract":"<div><h3>Introduction</h3><div>Electroconvulsive therapy (ECT) is a safe technique in which adverse effects are usually mild and self-limited. Posterior reversible encephalopathy syndrome (PRES) is a clinical-radiological entity characterized by encephalopathy, headache, seizures and visual alterations of acute evolution, caused by noxas that produce endothelial damage with vasogenic edema in the cerebral vessels. PRES has been described as a rare neurological complication associated of ECT. A case report is proposed to facilitate PRES recognition and management.</div></div><div><h3>Material and methods</h3><div>We present a clinical case report of a young woman with diagnosis of obsessive-compulsive disorder and eating disorder who was admitted due to a torpid evolution, who in the context of an ECT trial, suffered a PRES. Informed consent was obtained for every test performed, and for the use of their results in this publication. This publication complies with the agreements of the Declaration of Helsinki.</div></div><div><h3>Results</h3><div>The patient presented a spontaneous and complete recovery within a week, with no alterations on the MRI and no new neurological symptoms during admission or in the months after discharge. Even so, it was decided to suspend the ECT sessions.</div></div><div><h3>Discussion</h3><div>Patient’s symptoms were highly suggestive of PRES. MRI findings were unremarkable, which we attribute to the characteristic reversibility of the syndrome and the patients’ rapid clinical recovery after discontinuation of ECT.</div></div><div><h3>Conclusion</h3><div>Despite its reversibility and good prognosis, it is important to know this entity as a possible complication of ECT to facilitate its early recognition and improve the management and prognosis of our patients.</div></div>","PeriodicalId":39337,"journal":{"name":"Psiquiatria Biologica","volume":"32 2","pages":"Article 100515"},"PeriodicalIF":0.0,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142661802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Innovaciones en la cesación tabáquica: el papel de la citisiniclina","authors":"Miguel Angel Alvarez de Mon, Vanessa Herrera","doi":"10.1016/j.psiq.2024.100513","DOIUrl":"10.1016/j.psiq.2024.100513","url":null,"abstract":"<div><div>Tobacco use is one of the leading causes of disease, disability, and death worldwide. Achieving smoking cessation without pharmacological assistance is extremely challenging due to the highly addictive nature of tobacco. The goal of pharmacotherapy for nicotine addiction is to reduce withdrawal symptoms and nicotine's reinforcing effects with minimal side effects. Several effective medications are available to help people quit smoking, including nicotine replacement therapy (NRT), bupropion, varenicline, nortriptyline, and cytisinicline, among others. Cytisinicline has gained popularity in Spain, supported by funding from the Ministry of Health, making it more accessible through the public health system. Cytisinicline is administered orally and does not undergo significant hepatic metabolism, reducing the risk of drug interactions. Its most common side effects are gastrointestinal symptoms, which usually resolve spontaneously. Clinical trials have demonstrated its efficacy in smoking cessation. A clinical trial in Australia compared cytisinicline with varenicline, showing similar abstinence rates but with better tolerability for cytisinicline. Other studies and meta-analyses have also demonstrated the superiority of cytisinicline over NRT and placebo. Given its effectiveness, favorable side effect profile, and low cost, cytisinicline is a promising option. Combining it with behavioral support, such as cognitive-behavioral therapy (CBT) and motivational interviewing, enhances outcomes.</div></div>","PeriodicalId":39337,"journal":{"name":"Psiquiatria Biologica","volume":"31 4","pages":"Article 100513"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142586847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Risk of hospital readmission in patients with psychotic symptoms and a history of drug use","authors":"Paula Mollà Roig","doi":"10.1016/j.psiq.2024.100509","DOIUrl":"10.1016/j.psiq.2024.100509","url":null,"abstract":"<div><h3>Introduction</h3><div>Substance use is common in patients with psychotic symptomatology, especially in patients diagnosed with a first psychotic episode or schizophrenia. In both chronic psychosis and first psychotic episodes, substance abuse is associated with a worse outcome and a higher relapse rate.</div></div><div><h3>Methods</h3><div>For this study, a sample of <em>n</em> <!-->=<!--> <!-->731 was collected, including all patients hospitalised in the Adult Hospitalisation Unit (AHU) of Psychiatry of the Hospital Clínico Universitario de Zaragoza between 1 January 2014 and 31 December 2017, with a discharge diagnosis of psychotic disorder or affective disorder with psychotic symptomatology.</div></div><div><h3>Results</h3><div>From the analysis of the sample, the results show that 52.19% of the patients in the sample studied have a history of drug use. And, the most frequently used substance among patients with psychotic pathology is cannabis (73.71%). Likewise, patients with a history of drug use were admitted at an earlier age (35.07<!--> <!-->±<!--> <!-->12.72 years) than those without a history of drug use (50.74<!--> <!-->±<!--> <!-->15.08 years). In addition, drug use was more frequent in males, with a ratio of 4:1.</div></div><div><h3>Conclusions</h3><div>It has also been observed that patients with a history of drug use have a higher risk of hospital readmission to a psychiatric unit. In the sample analysed, cannabis was the only substance that presented statistically significant differences with respect to the risk of hospital readmission.</div></div>","PeriodicalId":39337,"journal":{"name":"Psiquiatria Biologica","volume":"31 4","pages":"Article 100509"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142420158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
